Vanderbilt Research Trending Archives
Oct. 13, 2016—In what could be a way to predict which children might be vulnerable to anxiety disorders, a Vanderbilt study has shown that an altered prefrontal cortex function in the brain marks a heightened anxiety risk in children.
Oct. 13, 2016—A Vanderbilt University study published today in the Journal of Clinical Psychiatry may help patients prescribed higher doses of certain antidepressants feel better about attributed cardiac risks.
Oct. 6, 2016—Scientists in the Vanderbilt Epidemiology Center (VEC) and Vanderbilt-Ingram Cancer Center (VICC) have been awarded a grant to plan and develop a Regional Center of Research Excellence in non-communicable diseases in Vietnam.
Sep. 29, 2016—Biases that people hold below the surface are influencing how they view this electoral season, as well as major political issues. Efrén Pérez is an expert and wrote a book on the topic.
Sep. 16, 2016—New ethical rules for scientists who do experiments involving human beings are about to kick in. It's the first update in more than 40 years.
Sep. 15, 2016—Researchers at Vanderbilt University Medical Center have discovered a key mechanism that explains how compounds they’re developing can suppress schizophrenia-like symptoms without side effects in mice.
Sep. 15, 2016—A research team led by structural biologists from Vanderbilt University has come up with the first detailed molecular explanation for a factor that may contribute to the so-called cystic fibrosis (CF) “gender gap.”
Sep. 9, 2016—As part of the national Cancer Moonshot initiative, a Blue Ribbon Panel (BRP) of cancer leaders, including four from Vanderbilt-Ingram Cancer Center, has delivered a series of recommendations to accelerate the pace of cancer prevention efforts and scientific discovery.
Sep. 1, 2016—A consortium led by Vanderbilt University Medical Center (VUMC) researchers has received funding as it makes plans for a multicenter trial that could determine whether deep brain stimulation (DBS) slows the progression of Parkinson’s disease in early-stage patients.